4//SEC Filing
Aptevo Therapeutics Inc. 4
Accession 0001019056-17-000550
$APVOCIK 0001671584operating
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 9:41 PM ET
Size
5.7 KB
Accession
0001019056-17-000550
Insider Transaction Report
Form 4
Stromatt Scott C
Chief Medical Officer and SVP
Transactions
- Award
Employee Stock Option (right to buy)
2017-06-01+33,700→ 33,700 totalExercise: $2.15Exp: 2027-05-31→ Common Stock (33,700 underlying)
Footnotes (2)
- [F1]The option grant was approved by a committee of Aptevo Therapeutics Inc.'s board of directors on February 22, 2017, subject to stockholder approval of the Amended and Restated 2016 Stock Incentive Plan (the "Plan") under which the option was granted. Aptevo Therapeutics Inc.'s stockholders approved the Plan on May 31, 2017.
- [F2]The option vests in three equal annual installments beginning on June 1, 2018.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001671584
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 9:41 PM ET
- Size
- 5.7 KB